CRP and chronic kidney disease: The prospective analysis from Spain corroborates thesefindings as patients with CKD presented increased inflammatory biomarker valuessuch as CRP (113.7 vs. 65.6 mg/L, p=0.009) and ferritin (1132 vs 8721ng/mL,p=0.04), and altered coagulation markers as elevated D-dimer (>1.7mg/dL (%)(56.5 vs. 34.7%, p<0.001) and prolonged activated partial thromboplastin time(46.1 vs. 38.5 s, p<0.001) than non-CKD patients with COVID-1920,21.